Table 2

Estimated aggregated health outcomes and costs of implementing a nation-wide diabetes prevention program in Germany

Population at high risk of developing type 2 diabetesLifetime reduction in incident cases of type 2 diabetes, casesLifetime reduction in incident cases of type 2 diabetes, %Lifetime reduction in the average number of years lived with type 2 diabetes, yearsLifetime reduction in the average number of years lived with type 2 diabetes, %Upfront cost in the first 2 years of implementing the program
(€, 2020)
Lifetime total costs of from a healthcare system perspective (€, 2020)Lifetime incremental costs from a healthcare system perspective (€, 2020)Lifetime total costs from a societal perspective (€, 2020)Lifetime incremental costs from a societal perspective (€, 2020)Lifetime incremental QALYs
Total NMean % of participating
Cohort 35–54 years
 2 308 625100%26 7882.060.030.65745 559 616145 348 605 401381 475 867588 466 202 230−98 799 11632 321
 1 154 31250%13 394372 779 64672 674 271 221190 737 851294 233 101 115−49 399 53714 572
 577 15625%6 697186 389 82336 337 135 61195 368 926147 116 598 239−24 699 7686889
 230 86210%2 67974 555 80014 534 829 06138 147 50458 846 620 223−9 879 8902660
 115 4315%1 33937 277 9007 267 414 53019 073 75229 423 262 431−4 939 9451314
Cohort 55–74 years
 6 170 870100%15 3193.960.060.931 967 541 011288 717 395 5401 363 007 102298 897 291 524434 170 950168 359
 3 085 43550%7 660983 770 505144 358 697 770681 503 551149 448 581 027217 085 47565 799
 1 542 71825%3 830491 885 41272 179 372 279340 751 88674 724 290 514108 542 77328 304
 617 08710%1 532196 754 10128 871 739 554136 300 71029 889 664 41843 417 09510 219
 30 8545%76698 376 89114 435 846 38368 150 24514 944 832 20921 708 5124 926
  • QALYs, quality-adjusted life years.